We are live on ! Find out more
GCIA

Gabelli & Co Investment Advisers Portfolio holdings

AUM $674M
1-Year Est. Return 64.46%
This Fund
S&P 500
This Quarter Est. Return
+8.85%
1 Year Est. Return
+64.46%
3 Year Est. Return
+233.2%
5 Year Est. Return
+564.06%
10 Year Est. Return
+5,311.56%
AUM
$598M
AUM Growth
+$76.5M
Cap. Flow
+$64.6M
Cap. Flow %
10.8%
Top 10 Hldgs %
39.45%
Holding
336
New
90
Increased
41
Reduced
12
Closed
71

Sector Composition

Rank Sector Weight
1 Technology 19.7%
2 Healthcare 18.49%
3 Financials 10.5%
4 Industrials 9.85%
5 Communication Services 7.48%

Similar funds

Gabelli & Co Investment Advisers's Q2 2023 Portfolio in Review

As of Q2 2023, Gabelli & Co Investment Advisers held 336 positions worth $598M, up 15% from $521M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Gabelli & Co Investment Advisers deployed $64.6M of net new capital in Q2 2023, opening 90 new positions and adding to 41 existing holdings. Its largest new stake was IVERIC bio, Inc. Common Stock: 684,950 shares worth $26.9M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Rogers Corp, an estimated $11.3M trimmed.

  • Gabelli & Co Investment Advisers's largest Q2 2023 buy was IVERIC bio, Inc. Common Stock: 684,950 shares worth $26.9M.
  • Gabelli & Co Investment Advisers added most to National Instruments Corp in Q2 2023, an estimated $17.7M increase.
  • Gabelli & Co Investment Advisers's biggest Q2 2023 reduction was Rogers Corp, cutting an estimated $11.3M.
  • Gabelli & Co Investment Advisers fully exited Oak Street Health, Inc. in Q2 2023, selling an estimated $25.9M.
  • Gabelli & Co Investment Advisers's ten largest holdings make up 39% of its $598M portfolio in Q2 2023.
  • Gabelli & Co Investment Advisers opened 90 new positions and closed 71 in Q2 2023.
  • Gabelli & Co Investment Advisers's portfolio value rose 15% quarter-over-quarter to $598M.

Based on Gabelli & Co Investment Advisers's 13F filing for Q2 2023, filed 10 Aug 2023.